Top

Gepubliceerd in:

10-07-2020

Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitus

Auteurs: Gabriel A. Benavidez, Kelly R. Ylitalo, Beth Lanning, Matt Asare, Andrew Meyer, Jackson O. Griggs

Gepubliceerd in: Quality of Life Research | Uitgave 12/2020

Abstract

Purpose

The purpose of this study was to measure the association between peripheral neuropathy symptoms and depressive symptoms among a sample of patients with and without diabetes mellitus (DM).

Methods

Patients were administered the 15-item Michigan Neuropathy Screening Instrument (MNSI) and the patient health questionnaire depression scale (PHQ-8). Patients with an MNSI score ≥ 4 were categorized as having PN and patients with a PHQ-8 score ≥ 10 were considered to have current depression. Log-binomial regression was used to analyze the relationship between PN and depressive symptoms.

Results

406 patients were included in the final analysis. There were no statistically significant differences by diabetes status in PN symptoms (Diabetes = 61.8%; No diabetes = 55.4%; p = .20) or in depression status (Diabetes = 37.6%; No diabetes = 36.6%; p = .83). After adjustment for covariates, PN was associated with depression (aRR = 4.46; 95% CI 2.91,6.85) independent of diabetes status.

Conclusions

PN symptoms may be common among aging persons even in the absence of DM. Past literature and our study demonstrate that PN and depression are closely associated. More work is needed to understand the etiology and potential utility of intervention for depression symptoms among patients with neuropathy.

vorige artikel Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation

volgende artikel Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial

Juster-Switlyk, K., & Smith, A. G. (2016). Updates in diabetic peripheral neuropathy. F1000 Research. https://doi.org/10.12688/f1000research.7898.1.CrossRefPubMed

Gregg, E. W., Sorlie, P., Paulose-Ram, R., et al. (2004). Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care, 27(7), 1591–1597. https://doi.org/10.2337/diacare.27.7.1591.CrossRefPubMed

Stino, A. M., & Smith, A. G. (2017). Peripheral neuropathy in prediabetes and the metabolic syndrome. Journal of Diabetes Investigation, 8(5), 646–655. https://doi.org/10.1111/jdi.12650.CrossRefPubMedPubMedCentral

Ylitalo, K. R., Sowers, M., & Heeringa, S. (2011). Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity. Diabetes Care, 34(7), 1642–1647. https://doi.org/10.2337/dc10-2150.CrossRefPubMedPubMedCentral

Miscio, G., Guastamacchia, G., Brunani, A., Priano, L., Baudo, S., & Mauro, A. (2005). Obesity and peripheral neuropathy risk: a dangerous liaison. Journal of the Peripheral Nervous System, 10(4), 354–358. https://doi.org/10.1111/j.1085-9489.2005.00047.x.CrossRefPubMed

Farhad, K., Traub, R., Ruzhansky, K. M., & Brannagan, T. H. (2016). Causes of neuropathy in patients referred as “idiopathic neuropathy”: Causes of Neuropathy. Muscle and Nerve, 53(6), 856–861. https://doi.org/10.1002/mus.24969.CrossRefPubMed

Gordon Smith, A., & Robinson, S. J. (2006). Idiopathic neuropathy, prediabetes and the metabolic syndrome. Journal of the Neurological Sciences, 242(1–2), 9–14. https://doi.org/10.1016/j.jns.2005.11.020.CrossRefPubMed

Baron, R., Binder, A., & Wasner, G. (2010). Review neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. The Lancet Neurology, 9(8), 807–819.CrossRef

Boulton, A. J. M. (2005). Management of diabetic peripheral neuropathy. Clinical Diabetes, 23(1), 9–15. https://doi.org/10.2337/diaclin.23.1.9.CrossRef

10.

Vileikyte, L., Leventhal, H., Gonzalez, J. S., et al. (2005). Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care, 28(10), 2378–2383. https://doi.org/10.2337/diacare.28.10.2378.CrossRefPubMed

11.

Vileikyte, L., Peyrot, M., Gonzalez, J. S., et al. (2009). Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: A longitudinal study. Diabetologia, 52(7), 1265–1273. https://doi.org/10.1007/s00125-009-1363-2.CrossRefPubMed

12.

Bai, J.-W., Lovblom, L. E., Cardinez, M., et al. (2017). Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes. Journal of Diabetes and Its Complications, 31(8), 1318–1324. https://doi.org/10.1016/j.jdiacomp.2017.05.002.CrossRefPubMed

13.

Gormsen, L., Rosenberg, R., Bach, F., & Jensen, T. (2010). Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. European Journal of Pain, 14(2), 127.e1–127.e8. https://doi.org/10.1016/j.ejpain.2009.03.010.CrossRef

14.

Yoshida, S., Hirai, M., Suzuki, S., Awata, S., & Oka, Y. (2009). Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry and Clinical Neurosciences, 63(1), 65–72. https://doi.org/10.1111/j.1440-1819.2008.01889.x.CrossRefPubMed

15.

Pan, S., Liu, Z.-W., Shi, S., et al. (2017). Hamilton rating scale for depression-24 (HAM-D 24) as a novel predictor for diabetic microvascular complications in type 2 diabetes mellitus patients. Psychiatry Research, 258, 177–183. https://doi.org/10.1016/j.psychres.2017.07.050.CrossRefPubMed

16.

Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17(11), 1281–1289. https://doi.org/10.2337/diacare.17.11.1281.CrossRefPubMed

17.

Herman, W. H., Pop-Busui, R., Braffett, B. H., et al. (2012). Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabetic Medicine, 29(7), 937–944. https://doi.org/10.1111/j.1464-5491.2012.03644.x.CrossRefPubMedPubMedCentral

18.

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

19.

Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173. https://doi.org/10.1016/j.jad.2008.06.026.CrossRefPubMed

20.

Wells, T. S., Horton, J. L., LeardMann, C. A., Jacobson, I. G., & Boyko, E. J. (2013). A comparison of the PRIME-MD PHQ-9 and PHQ-8 in a large military prospective study, the Millennium Cohort Study. Journal of Affective Disorders, 148(1), 77–83. https://doi.org/10.1016/j.jad.2012.11.052.CrossRefPubMed

21.

Dhingra, S. S., Kroenke, K., Zack, M. M., Strine, T. W., & Balluz, L. S. (2011). PHQ-8 Days: A measurement option for DSM-5 major depressive disorder (MDD) severity. Population Health Metrics. https://doi.org/10.1186/1478-7954-9-11.CrossRefPubMedPubMedCentral

22.

Spiegelman, D., & Easy, S. A. S. (2005). Calculations for risk or prevalence ratios and differences. American Journal of Epidemiology, 162(3), 199–200. https://doi.org/10.1093/aje/kwi188.CrossRefPubMed

23.

D’Amato, C., Morganti, R., Greco, C., et al. (2016). Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities. Diabetes & Vascular Disease Research, 13(6), 418–428. https://doi.org/10.1177/1479164116653240.CrossRef

24.

Rekleiti, M., Sarafis, P., Saridi, M., et al. (2013). Investigation of depression in greek patients with diabetic peripheral neuropathy. Global Journal of Health Science, 5(5), 107–114. https://doi.org/10.5539/gjhs.v5n5p107.CrossRefPubMedPubMedCentral

25.

Raval, A., Dhanaraj, E., Bhansali, A., Grover, S., & Tiwari, P. (2010). Prevalence & determinants of depression in type 2 diabetes patients. Indian Journal of Medical Research, 132(2), 195.PubMed

26.

Stankovik, Ž. (2010). Psychosocial and clinical variables associated with depression in patients with type 2 diabetes. Psychiatria Danubina, 23(1), 11.

27.

Ishizawa, K., Babazono, T., Horiba, Y., et al. (2016). The relationship between depressive symptoms and diabetic complications in elderly patients with diabetes: Analysis using the Diabetes Study from the Center of Tokyo Women’s Medical University (DIACET). Journal of Diabetes and Its Complications, 30(4), 597–602. https://doi.org/10.1016/j.jdiacomp.2016.02.004.CrossRefPubMed

28.

Rodda, J., Walker, Z., & Carter, J. (2011). Depression in older adults. BMJ, 343, d5219. https://doi.org/10.1136/bmj.d5219.CrossRefPubMed

29.

Cuijpers, P., de Graaf, R., & van Dorsselaer, S. (2004). Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. Journal of Affective Disorders, 79(1–3), 71–79. https://doi.org/10.1016/S0165-0327(02)00348-8.CrossRefPubMed

30.

Lewis Brown, R., & Turner, R. J. (2010). Physical disability and depression: Clarifying racial/ethnic contrasts. Journal of Aging and Health, 22(7), 977–1000. https://doi.org/10.1177/0898264309360573.CrossRefPubMed

31.

Verbrugge, L. M., & Jette, A. M. (1994). The disablement process. Social Science & Medicine, 38(1), 1–14.CrossRef

32.

Resnick, H. E., Vinik, A. I., Schwartz, A. V., et al. (2000). Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: The Women’s Health and Aging Study. Diabetes Care, 23(11), 1642–1647. https://doi.org/10.2337/diacare.23.11.1642.CrossRefPubMed

33.

Karvonen-Gutierrez, C. A., & Ylitalo, K. R. (2013). Prevalence and correlates of disability in a late middle-aged population of women. Journal of Aging and Health, 25(4), 701–717. https://doi.org/10.1177/0898264313488165.CrossRefPubMedPubMedCentral

34.

Tesfaye, S. (2019). Neuropathy in diabetes. Medicine (Baltimore), 47(2), 92–99. https://doi.org/10.1016/j.mpmed.2018.11.009.CrossRef

35.

Iqbal, Z., Azmi, S., Yadav, R., et al. (2018). Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy. Clinical Therapeutics, 40(6), 828–849. https://doi.org/10.1016/j.clinthera.2018.04.001.CrossRefPubMed

36.

England, J. D., Gronseth, G. S., Franklin, G., et al. (2009). Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology., 72(2), 177–184. https://doi.org/10.1212/01.wnl.0000336345.70511.0f.CrossRefPubMed

37.

U.S. Preventive Services Task Force. Published Recommendations-US Preventive Services Task Force. Published June 2019. Accessed June 20, 2019. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index.

38.

Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., et al. (2017). Diabetic neuropathy: A position statement by the american diabetes association. Diabetes Care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042.CrossRefPubMed

39.

Watson, J. C., & Dyck, P. J. B. (2015). Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clinic Proceedings, 90(7), 940–951. https://doi.org/10.1016/j.mayocp.2015.05.004.CrossRefPubMed

40.

Abresch, R. T., Jensen, M. P., & Carter, G. T. (2001). Health-related quality of life in peripheral neuropathy. Physical Medicine and Rehabilitation Clinics of North America, 12(2), 461–472.CrossRef

41.

Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015). Depression and quality of life in older persons: A review. Dementia and Geriatric Cognitive Disorders, 40(5–6), 311–339. https://doi.org/10.1159/000437299.CrossRefPubMed

Titel: Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitus
Auteurs: Gabriel A. Benavidez
Kelly R. Ylitalo
Beth Lanning
Matt Asare
Andrew Meyer
Jackson O. Griggs
Publicatiedatum: 10-07-2020
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 12/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02579-2

Andere artikelen Uitgave 12/2020

Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry

Open Access

Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation

Registered Reports: clarifications and opportunities from ISOQOL’S Special Interest Group for Clinical Practice

Letter to the Editor

Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose

Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD)

Bohn Stafleu van Loghum

Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitus

Abstract

Purpose

Methods

Results

Conclusions

Andere artikelen Uitgave 12/2020

Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry

Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation

Registered Reports: clarifications and opportunities from ISOQOL’S Special Interest Group for Clinical Practice

Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose

Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD)

Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry

Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation

Registered Reports: clarifications and opportunities from ISOQOL’S Special Interest Group for Clinical Practice

Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose

Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD)

Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus